Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

Introduuction: Alopecia areata (AA) is a common cause of non-scarring alopecia with
variable response to treatment. Platelet-rich plasma (PRP) stimulates proliferation and …

There are no widely accepted therapy protocols for severe alopecia areata (AA). We treated
65 children/adolescents with AA affecting> 30% of scalp. Fourty‐three percent of patients …

Background: In alopecia totalis (AT) and alopecia universalis (AU), the chance of full hair
regrowth is known to be less than 10%. However, this information is based on a few older …

Background: Alopecia areata is an autoimmune disease leading to nonscarring hair loss on
the scalp or body. There are different treatments including immunosuppressants, hair growth …

There is no universally accepted treatment for severe pediatric alopecia areata (AA). This
prospective study comprised 73 patients (aged 1–18 years) with severe AA (> 30% of scalp …

Atopy may be a facilitating factor in some alopecia areata (AA) patients with early disease
onset and more severe/extensive AA. The underlying immune mechanisms are unknown …

Abstract Background Long noncoding RNAs (lncRNAs) regulate gene expression by acting
with microRNAs (miRNAs) and indirectly interact with messenger RNA (mRNAs). However …

Figure 1: Alopecia areata sisaipho: temporal and occipital scalp hair clearance usually
involving vertex and avoiding ophiasic areas:(a) Initial pattern of hair loss;(b) evolution after …

Background/Objectives Alopecia areata (AA) is a T-cell driven autoimmune disease, which
results in hair loss. This study aims to determine the efficacy, tolerability and safety of …